Cargando…

Evaluation of pharmaceutical industry-led access programmes: a standardised framework

Pharmaceutical industry-led access programmes are increasing in number and scope worldwide. We present a new standardised framework for evaluation of these programmes that includes three components: a taxonomy of 11 access programme strategies; a series of logic models, one for each strategy and a s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rockers, Peter C, Laing, Richard O, Scott, Nancy, Ashigbie, Paul, Lucca, Erin H, Umeh, Chukwuemeka Anthony, Wirtz, Veronika J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688691/ https://www.ncbi.nlm.nih.gov/pubmed/31423348 http://dx.doi.org/10.1136/bmjgh-2019-001659

Ejemplares similares

Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist
por: Umeh, Chukwuemeka A., et al.
Publicado: (2020)

Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya
por: Rockers, Peter C, et al.
Publicado: (2016)

Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study
por: Onyango, Monica Adhiambo, et al.
Publicado: (2018)

Digital Health Technologies Applied by the Pharmaceutical Industry to Improve Access to Noncommunicable Disease Care in Low- and Middle-Income Countries
por: Heerdegen, Anne Christine Stender, et al.
Publicado: (2022)

Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya
por: Rockers, Peter C, et al.
Publicado: (2018)

Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight counties
por: Ashigbie, Paul G, et al.
Publicado: (2020)

Phone-based monitoring to evaluate health policy and program implementation in Kenya
por: Ashigbie, Paul G, et al.
Publicado: (2021)

Ethical considerations of publication planning in the pharmaceutical industry
por: Fugh-Berman, Adriane, et al.
Publicado: (2008)

Use of standardised patients for healthcare quality research in low- and middle-income countries
por: Kwan, Ada, et al.
Publicado: (2019)

The need for standardised methods of data collection, sharing of data and agency coordination in humanitarian settings
por: Shalash, Aisha, et al.
Publicado: (2022)

Applying a health system perspective to the evolving Farmácia Popular medicines access programme in Brazil
por: Luiza, Vera L, et al.
Publicado: (2018)

Framework and strategy for integrated monitoring and evaluation of child health programmes for responsive programming, accountability, and impact
por: Diaz, Theresa, et al.
Publicado: (2018)

Household access to non-communicable disease medicines during universal health care roll-out in Kenya: A time series analysis
por: Kiragu, Zana Wangari, et al.
Publicado: (2022)

Pharmaceutical security for Canada
por: Lee, Shoo K., et al.
Publicado: (2022)

A comprehensive framework identifying barriers to global health R&D innovation and access
por: Ong, Ming
Publicado: (2023)

Refocusing vitamin A supplementation programmes to reach the most vulnerable
por: McLean, Erin, et al.
Publicado: (2020)

Coping with access barriers to non‐communicable disease medicines: qualitative patient interviews in eight counties in Kenya
por: Ng, Gloria, et al.
Publicado: (2021)

Challenges of medicines management in the public and private sector under Ghana’s National Health Insurance Scheme – A qualitative study
por: Ashigbie, Paul G., et al.
Publicado: (2016)

Making pharmaceutical research and regulation work for women
por: Ravindran, TK Sundari, et al.
Publicado: (2020)

Estimating the Burden of Chagas Disease in the United States
por: Manne-Goehler, Jennifer, et al.
Publicado: (2016)

Non-pharmaceutical interventions during the roll out of covid-19 vaccines
por: Zhang, Yi, et al.
Publicado: (2021)

Making the health system work by and for Indigenous women in Guatemala: a community led multisectoral collaboration
por: Velásquez, Claudia Nieves, et al.
Publicado: (2018)

Insights from a qualitative study of the procurement and manufacture of active pharmaceutical ingredients in India
por: Hamill, Heather, et al.
Publicado: (2023)

The emperor has no clothes: a synthesis of findings from the Transformative Research on the Alcohol industry, Policy and Science research programme
por: McCambridge, Jim, et al.
Publicado: (2022)

Optimising the reach of mobile health messaging programmes: an analysis of system generated data for the Kilkari programme across 13 states in India
por: Mohan, Diwakar, et al.
Publicado: (2022)

Tackling HIV by empowering adolescent girls and young women: a multisectoral, government led campaign in South Africa
por: Subedar, Hasina, et al.
Publicado: (2018)

Remarks on the Reform of the Pharmaceutical Nomenclature
Publicado: (1808)

Can we import improvements from industry to healthcare?
por: Macrae, Carl, et al.
Publicado: (2019)

Exposing drug industry funding of UK patient organisations
por: Ozieranski, Piotr, et al.
Publicado: (2019)

Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China
por: Yuan, Jing, et al.
Publicado: (2021)

Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
por: Kaplan, Warren A., et al.
Publicado: (2017)

Toward a definition of pharmaceutical innovation
por: Morgan, Steven, et al.
Publicado: (2008)

Implementing shared decision making in the NHS: lessons from the MAGIC programme
por: Joseph-Williams, Natalie, et al.
Publicado: (2017)

Elements of a strategic approach for strengthening national mortality statistics programmes
por: Rao, Chalapati
Publicado: (2019)

Government support for alcohol industry: promoting exports, jeopardising global health?
por: Collin, Jeff, et al.
Publicado: (2014)

The implementation of pharmaceutical services in public hospitals in Mexico: an analysis of the legal framework and organizational practice
por: Vargas López, Laura C., et al.
Publicado: (2021)

Methods for the strategic review of programmes for integrated management of childhood illness and community cases
por: Dalglish, Sarah L
Publicado: (2018)

Immunisation financing and programme performance in the Middle East and North Africa, 2010 to 2017
por: Saxenian, Helen, et al.
Publicado: (2019)

Tailored support for national NCD policy and programme implementation: an over-looked priority
por: Jackson-Morris, Angela, et al.
Publicado: (2020)

Assessing data bias in visual surveys from a cetacean monitoring programme
por: Oliveira-Rodrigues, Cláudia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lgbuon4slguvbivebk2qq3ih3v